Y042-6937 Screening compound: N~1~-[2-(1H-1,3-benzimidazol-2-yl)ethyl]-2-(3-oxo-2,3-dihydro-1H-isoindol-1-yl)acetamide

Y042-6937 Screening compound: N~1~-[2-(1H-1,3-benzimidazol-2-yl)ethyl]-2-(3-oxo-2,3-dihydro-1H-isoindol-1-yl)acetamide
Y042-6937 Screening compound: N~1~-[2-(1H-1,3-benzimidazol-2-yl)ethyl]-2-(3-oxo-2,3-dihydro-1H-isoindol-1-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y042-6937
N~1~-[2-(1H-1,3-benzimidazol-2-yl)ethyl]-2-(3-oxo-2,3-dihydro-1H-isoindol-1-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y042-6937

Molecular Formula

C19H18N4O2 (C19 H18 N4 O2)

Compound Name

N~1~-[2-(1H-1,3-benzimidazol-2-yl)ethyl]-2-(3-oxo-2,3-dihydro-1H-isoindol-1-yl)acetamide

IUPAC name

N-[2-(1H-13-benzodiazol-2-yl)ethyl]-2-(3-oxo-23-dihydro-1H-isoindol-1-yl)acetamide

SMILES

O=C(CC(c1c2cccc1)NC2=O)NCCc1nc(cccc2)c2[nH]1

InChI

InChI=1S/C19H18N4O2/c24-18(11-16-12-5-1-2-6-13(12)19(25)23-16)20-10-9-17-21-14-7-3-4-8-15(14)22-17/h1-8,16H,9-11H2,(H,20,24)(H,21,22)(H,23,25)/t16-/m1/s1

InChI Key

YQONYRQXKFFGIG-MRXNPFEDSA-N

MDL Number (MFCD)

MFCD28058846

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

334.38

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

1.453

Distribution Coefficient, logD

1.439

Water Solubility, LogSw

-2.21

Polar Surface Area

70.623

Acid Dissociation Constant (pKa)

11.44

Base Dissociation Constant (pKb)

5.90

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

21.05

Y042-6937 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system

References: we are preparing a list of scientific research reports with Y042-6937 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y042-6937?
Check Price and Availability of Y042-6937, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y042-6937 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y042-6937
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y042-6937
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y042-6937 available by request